Dr. Gabriele Dallmann

Dr. Gabriele Schaeffner-Dallmann is an internationally renowned expert with more than 25 years of experience in drug development and regulatory affairs of biopharmaceuticals. At the Paul-Ehrlich-Institut where she was Head of the Section "Mono- and polyclonal antibodies” she has been involved in the European process of authorisation of biopharmaceuticals and represented the PEI in committees and working parties of the EMA in London. Currently, Dr. Dallmann works as a consultant and is involved in development, strategic and market access projects. She is the founder of Pharmatching.com, an internet platform supporting outsourcing.
Stimulated by discussions on the lack of an adequate training platform providing young professionals with the distinctive knowledge on biopharmaceutical-related regulatory affairs she initiated an intensive dialogue with distinguished experts from authorities, universities and companies to develop EUCRAF.
As biologist with a PhD in immunology from Berlin University, she is also visiting lecturer on biopharmaceuticals at Freiburg University.

Prof. Jean-Yves Pabst

Jean-Yves Pabst is a pharmacist and professor in pharmaceutical law and economics. Since 2007 he is the dean of the Faculty of Pharmacy of the Universtity of Strasbourg. Since then he has been committed in the organization of partnerships with other Universities of the region in order to ensure the complementarity of both initial training and life-long learning.In 2005 he established the major subject “European law and regulatory affairs” for the Masters degree in Drug Science with the active support of the Strasbourg Law Faculty and the European Directorate for the Quality of Medicines. Jean-Yves Pabst has over 18 years experience as a pharmacist in regulatory affairs in the pharmaceutical industry.